Follow up by General Practitioner After Self-poisoning

This study has been completed.
Sponsor:
Collaborators:
University Hospital, Akershus
Lovisenberg Diakonale Hospital
Diakonhjemmet Hospital
Information provided by (Responsible Party):
Tine K. Grimholt, Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01342809
First received: April 18, 2011
Last updated: May 6, 2014
Last verified: May 2014
  Purpose

The study hypothesis is that follow up from general practitioner after hospitalization for self poisoning will decrease suicidal behaviour.


Condition Intervention
Suicidal and Self-injurious Behaviour
Behavioral: Follow up

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Follow up After Self-poisoning by General Practitioner- a Randomised Clinical Trial

Resource links provided by NLM:


Further study details as provided by Oslo University Hospital:

Primary Outcome Measures:
  • Suicidal behaviour [ Time Frame: 3 and 6 months ] [ Designated as safety issue: No ]
    Beck Cepression Inventory, Beck Hopelessness scale, Beck Suicide Ideation Scale

  • Suicidal behaviour [ Time Frame: 3 and 6 months ] [ Designated as safety issue: No ]
    Beck Depression Inventory, Beck Hopelessness scale, Beck Suicide Ideation Scale


Secondary Outcome Measures:
  • Treatment [ Time Frame: 3 and 6 months ] [ Designated as safety issue: No ]
    Contacts with GP, and health care services, satisfaction with treatment GP (EUROPEP)


Enrollment: 202
Study Start Date: November 2009
Study Completion Date: May 2014
Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Follow up
Close follow up from written guidelines, supervision provided.
Behavioral: Follow up
Follow up, consultations with general practitioner, written guidelines, supervision.
Other Name: General Practitioner
No Intervention: Usual Treatment

Detailed Description:

Patients hospitalized after an episode of self poisoning will be randomly assigned into intervention an control groups. The intervention is close follow up by general practitioner six months. Both groups will receive treatment as usual.

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Self Poisoning (according to the WHO definition)
  • Ability to fill out questionnaire

Exclusion Criteria:

  • Hospitalization into psychiatric ward
  • Unknown address or ID
  • Not registered with General Practitioner
  • If institutionalized or in jail.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01342809

Locations
Norway
Oslo University Hospital
Oslo, Norway, 0424
Sponsors and Collaborators
Oslo University Hospital
University Hospital, Akershus
Lovisenberg Diakonale Hospital
Diakonhjemmet Hospital
  More Information

No publications provided

Responsible Party: Tine K. Grimholt, Phd candidate, Oslo University Hospital
ClinicalTrials.gov Identifier: NCT01342809     History of Changes
Other Study ID Numbers: S-08708b
Study First Received: April 18, 2011
Last Updated: May 6, 2014
Health Authority: Norway: Oslo University Hospital Personvernombudet

Keywords provided by Oslo University Hospital:
Depression
Hopelessness
Suicidal ideation

Additional relevant MeSH terms:
Poisoning
Self-Injurious Behavior
Chemically-Induced Disorders
Behavioral Symptoms

ClinicalTrials.gov processed this record on August 28, 2014